Drug discovery - 2 News by BenevolentAI
Tip: You can further refine your news selection by countries.
Merck Enters Two Strategic Collaborations to Strengthen AI-driven Drug Discovery
Partnerships with BenevolentAI and Exscientia to drive accelerated drug discovery with higher probability of success
20-Sep-2023 - Merck announced two new strategic drug discovery collaborations aimed at harnessing powerful artificial intelligence (AI)-driven design and discovery capabilities, further advancing the company’s research efforts. The partnerships, with BenevolentAI, London, U.K., and Exscientia, Oxford, U.K., ...
AstraZeneca starts collaboration with start-up BenevolentAI
Collaboration will use artificial intelligence to discover potential new drugs
02-May-2019 - AstraZeneca and BenevolentAI began a long-term collaboration to use artificial intelligence (AI) and machine learning for the discovery and development of new treatments for chronic kidney disease (CKD) and idiopathic pulmonary fibrosis (IPF). Scientists from the two organisations will work ...
Haven't found the right news yet?
The bionity.com news search
Start your targeted search now with a wide range of filter options. Our database includes an archive of 25,067 life science news from business and science, which you can search by topic and organization, filtered by time and geography.